154 related articles for article (PubMed ID: 32015503)
1. MARCH5-dependent degradation of MCL1/NOXA complexes defines susceptibility to antimitotic drug treatment.
Haschka MD; Karbon G; Soratroi C; O'Neill KL; Luo X; Villunger A
Cell Death Differ; 2020 Aug; 27(8):2297-2312. PubMed ID: 32015503
[TBL] [Abstract][Full Text] [Related]
2. MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activation.
Arai S; Varkaris A; Nouri M; Chen S; Xie L; Balk SP
Elife; 2020 Jun; 9():. PubMed ID: 32484436
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of MARCH5 ubiquitin ligase abrogates MCL1-dependent resistance to BH3 mimetics via NOXA.
Subramanian A; Andronache A; Li YC; Wade M
Oncotarget; 2016 Mar; 7(13):15986-6002. PubMed ID: 26910119
[TBL] [Abstract][Full Text] [Related]
4. MARCH5 requires MTCH2 to coordinate proteasomal turnover of the MCL1:NOXA complex.
Djajawi TM; Liu L; Gong JN; Huang AS; Luo MJ; Xu Z; Okamoto T; Call MJ; Huang DCS; van Delft MF
Cell Death Differ; 2020 Aug; 27(8):2484-2499. PubMed ID: 32094511
[TBL] [Abstract][Full Text] [Related]
5. MARCH5 regulates mitotic apoptosis through MCL1-dependent and independent mechanisms.
Wang Y; Poon RYC
Cell Death Differ; 2023 Mar; 30(3):753-765. PubMed ID: 36329234
[TBL] [Abstract][Full Text] [Related]
6. The NOXA-MCL1-BIM axis defines lifespan on extended mitotic arrest.
Haschka MD; Soratroi C; Kirschnek S; Häcker G; Hilbe R; Geley S; Villunger A; Fava LL
Nat Commun; 2015 Apr; 6():6891. PubMed ID: 25922916
[TBL] [Abstract][Full Text] [Related]
7. Targeting a mitochondrial E3 ubiquitin ligase complex to overcome AML cell-intrinsic Venetoclax resistance.
Nakao F; Setoguchi K; Semba Y; Yamauchi T; Nogami J; Sasaki K; Imanaga H; Terasaki T; Miyazaki M; Hirabayashi S; Miyawaki K; Kikushige Y; Masuda T; Akashi K; Maeda T
Leukemia; 2023 May; 37(5):1028-1038. PubMed ID: 36973350
[TBL] [Abstract][Full Text] [Related]
8. Mitosis and apoptosis: how is the balance set?
Topham CH; Taylor SS
Curr Opin Cell Biol; 2013 Dec; 25(6):780-5. PubMed ID: 23890995
[TBL] [Abstract][Full Text] [Related]
9. Metformin enhances TRAIL-induced apoptosis by Mcl-1 degradation via Mule in colorectal cancer cells.
Park SH; Lee DH; Kim JL; Kim BR; Na YJ; Jo MJ; Jeong YA; Lee SY; Lee SI; Lee YY; Oh SC
Oncotarget; 2016 Sep; 7(37):59503-59518. PubMed ID: 27517746
[TBL] [Abstract][Full Text] [Related]
10. Mcl-1 dynamics influence mitotic slippage and death in mitosis.
Sloss O; Topham C; Diez M; Taylor S
Oncotarget; 2016 Feb; 7(5):5176-92. PubMed ID: 26769847
[TBL] [Abstract][Full Text] [Related]
11. MARCH5-mediated quality control on acetylated Mfn1 facilitates mitochondrial homeostasis and cell survival.
Park YY; Nguyen OT; Kang H; Cho H
Cell Death Dis; 2014 Apr; 5(4):e1172. PubMed ID: 24722297
[TBL] [Abstract][Full Text] [Related]
12. Novel regulatory roles of Mff and Drp1 in E3 ubiquitin ligase MARCH5-dependent degradation of MiD49 and Mcl1 and control of mitochondrial dynamics.
Cherok E; Xu S; Li S; Das S; Meltzer WA; Zalzman M; Wang C; Karbowski M
Mol Biol Cell; 2017 Feb; 28(3):396-410. PubMed ID: 27932492
[TBL] [Abstract][Full Text] [Related]
13. A simplified Bcl-2 network model reveals quantitative determinants of cell-to-cell variation in sensitivity to anti-mitotic chemotherapeutics.
Kueh HY; Zhu Y; Shi J
Sci Rep; 2016 Nov; 6():36585. PubMed ID: 27811996
[TBL] [Abstract][Full Text] [Related]
14. The carboxyl-terminal tail of Noxa protein regulates the stability of Noxa and Mcl-1.
Pang X; Zhang J; Lopez H; Wang Y; Li W; O'Neill KL; Evans JJ; George NM; Long J; Chen Y; Luo X
J Biol Chem; 2014 Jun; 289(25):17802-11. PubMed ID: 24811167
[TBL] [Abstract][Full Text] [Related]
15. Noxa controls Mule-dependent Mcl-1 ubiquitination through the regulation of the Mcl-1/USP9X interaction.
Gomez-Bougie P; Ménoret E; Juin P; Dousset C; Pellat-Deceunynck C; Amiot M
Biochem Biophys Res Commun; 2011 Sep; 413(3):460-4. PubMed ID: 21907705
[TBL] [Abstract][Full Text] [Related]
16. The anti-apoptotic protein BCL2L1/Bcl-xL is neutralized by pro-apoptotic PMAIP1/Noxa in neuroblastoma, thereby determining bortezomib sensitivity independent of prosurvival MCL1 expression.
Hagenbuchner J; Ausserlechner MJ; Porto V; David R; Meister B; Bodner M; Villunger A; Geiger K; Obexer P
J Biol Chem; 2010 Mar; 285(10):6904-12. PubMed ID: 20051518
[TBL] [Abstract][Full Text] [Related]
17. Regulation of heat-induced apoptosis by Mcl-1 degradation and its inhibition by Hsp70.
Stankiewicz AR; Livingstone AM; Mohseni N; Mosser DD
Cell Death Differ; 2009 Apr; 16(4):638-47. PubMed ID: 19148187
[TBL] [Abstract][Full Text] [Related]
18. Noxa determines localization and stability of MCL-1 and consequently ABT-737 sensitivity in small cell lung cancer.
Nakajima W; Hicks MA; Tanaka N; Krystal GW; Harada H
Cell Death Dis; 2014 Feb; 5(2):e1052. PubMed ID: 24525728
[TBL] [Abstract][Full Text] [Related]
19. A novel BH3 mimetic efficiently induces apoptosis in melanoma cells through direct binding to anti-apoptotic Bcl-2 family proteins, including phosphorylated Mcl-1.
Liu Y; Xie M; Song T; Sheng H; Yu X; Zhang Z
Pigment Cell Melanoma Res; 2015 Mar; 28(2):161-70. PubMed ID: 25324174
[TBL] [Abstract][Full Text] [Related]
20. Confounding off-target effects of BH3 mimetics at commonly used concentrations: MIM1, UMI-77, and A-1210477.
Mallick DJ; Soderquist RS; Bates D; Eastman A
Cell Death Dis; 2019 Feb; 10(3):185. PubMed ID: 30796196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
